PARK7 and non-small cell lung carcinoma: In some cancers, such as endometrial cancer, non-small cell lung cancer, pancreatic cancer, esophageal squamous cell carcinoma, and cervical cancer, high expression of PARK7 is significantly associated with metastasis or worse prognosis [21].